Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Expression and purification of the 5′-nucleotidase YitU from Bacillus species: its enzymatic properties and possible applications in biotechnology

  • 155 Accesses

Abstract

5’-Nucleotidases (EC 3.1.3.5) are enzymes that catalyze the hydrolytic dephosphorylation of 5′-ribonucleotides and 5′-deoxyribonucleotides to their corresponding nucleosides plus phosphate. In the present study, to search for new genes encoding 5′-nucleotidases specific for purine nucleotides in industrially important Bacillus species, “shotgun” cloning and the direct selection of recombinant clones grown in purine nucleosides at inhibitory concentrations were performed in the Escherichia coli GS72 strain, which is sensitive to these compounds. As a result, orthologous yitU genes from Bacillus subtilis and Bacillus amyloliquefaciens, whose products belong to the ubiquitous haloacid dehalogenase superfamily (HADSF), were selected and found to have a high sequence similarity of 87%. B. subtilis YitU was produced in E. coli as an N-terminal hexahistidine-tagged protein, purified and biochemically characterized as a soluble 5′-nucleotidase with broad substrate specificity with respect to various deoxyribo- and ribonucleoside monophosphates: dAMP, GMP, dGMP, CMP, AMP, XMP, IMP and 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranosyl 5′-monophosphate (AICAR-P). However, the preferred substrate for recombinant YitU was shown to be flavin mononucleotide (FMN). B. subtilis and B. amyloliquefaciens yitU overexpression increased riboflavin (RF) and 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) accumulation and can be applied to breed highly performing RF- and AICAR-producing strains.

Introduction

Bacillus subtilis, Bacillus amyloliquefaciens, and other Bacillus species are gram-positive bacteria widely used for the production of enzymes, recombinant proteins, antimicrobial components (peptide and lipopeptide antibiotics and bacteriocins), insecticides, adsorbents, surfactants, and other industrially important biochemicals such as d-ribose, vitamins, purine nucleosides, and poly(gamma-glutamic acid) (Schallmey et al. 2004; Abriouel et al. 2011; Liu et al. 2013).

The main desirable features for the application of many Bacillus species as microbial cell factories are their generally recognized as safe (GRAS) status, probiotic properties, absence of exotoxins and endotoxin production, fully sequenced genomes, well-studied secretion pathways, and fairly simple cultivation conditions; their available transcriptome, metabolome, and proteome analysis data, and advanced genetic engineering tools are suitable for use with these species. B. subtilis and B. amyloliquefaciens strains have been successfully designed to produce riboflavin (RF), adenosine, inosine, guanosine, and 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), which are widely used in food technology and the pharmaceutical industry (Stepanov et al. 1984; Perkins et al. 1999; Asahara et al. 2010; Lobanov et al. 2011; Sheremet et al. 2011; Zhang et al. 2015). Since the compounds listed can be synthesized from their immediate phosphorylated precursors, flavin mononucleotide (FMN), AMP, IMP, GMP, and 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranosyl 5′-monophosphate (AICAR-P), respectively, the construction of industrial producers requires not only enhanced metabolic flux towards the biosynthesis of these phosphorylated compounds but also the oversynthesis of enzymes with respective phosphatase or 5′-nucleotidase activity. 5’-Nucleotidases (EC 3.1.3.5) are enzymes that catalyze the hydrolytic dephosphorylation of 5′-ribonucleotides and 5′-deoxyribonucleotides to nucleosides and phosphate. These enzymes are widely distributed among all domains of life (Zimmermann 1992). Most well-studied soluble 5′-nucleotidases belong to the ubiquitous haloacid dehalogenase superfamily (HADSF) and have been shown to be involved in purine and pyrimidine salvage pathways, nucleic acid repair, cell-to-cell communication, signal transduction, etc. (Bianchi and Spychala 2003; Hunsucker et al. 2005; Borowiec et al. 2006). HADSF members, which are multifunctional enzymes with 5′-nucleotidase activity expressed by bacteria, control the intracellular concentrations of key phosphorylated metabolites and thereby participate in regulating cellular metabolism. The identification and investigation of these enzymes are important from both fundamental and applied points of view.

Despite the essential role of soluble 5′-nucleotidases in bacterial metabolism and the design of industrially important strains, little information about the functions of these enzymes from Bacillus species could be found in the literature. Terakawa and coauthors reported the 5′-nucleotidase activities of several B. subtilis proteins (YqeG, YcaA, YutF, YcsE, and YktC) (Terakawa et al. 2016) homologous to earlier described E. coli multifunctional enzymes that exhibit 5′-nucleotidase activity with respect to a remarkably broad and overlapping substrate spectrum (Matsuhisa et al. 1995; Kuznetsova et al. 2006). A HADSF member from B. subtilis, the 5′-nucleotidase YutF, was found to hydrolyze various purine and pyrimidine 5′-nucleotides, showing a preference for 5′-nucleoside monophosphates and, specifically, 5’-XMP (Zakataeva et al. 2016). Recently, enzymes with phosphatase and 5′-nucleotidase activities belonging to the HADSF were shown to catalyze essential steps in the biosynthesis of the key cellular metabolites serine and RF. Thus, YsaA from B. subtilis was found to be a phosphoserine phosphatase, the enzyme that catalyzes the final step of serine biosynthesis (Koo et al. 2017). Another HADSF member, B. subtilis YcsE, was shown to catalyze the dephosphorylation of 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione 5′-phosphate (ARPP), forming the pyrimidine precursor of RF, 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione (Sarge et al. 2015). Moreover, screening of 13 putative HADSF members from B. subtilis revealed that two additional proteins, YwtE and YitU, can catalyze the same reaction at appreciable rates (Sarge et al. 2015). Recently, a homologue of YwtE and YcsE, B. subtilis PhoC, which is probably involved in the phosphosugar stress response, was characterized (Morabbi Heravi et al. 2019).

In the present study, to search for genes encoding 5′-nucleotidases specific to purine nucleotides in B. subtilis and B. amyloliquefaciens, “shotgun” cloning and the direct selection of recombinant clones grown with purine nucleosides at inhibitory concentrations were performed in the E. coli GS72 strain, which is sensitive to these compounds. As a result, the yitU gene was selected, and its product was characterized as a 5′-nucleotidase with broad substrate specificity with respect to various deoxyribo- and ribonucleoside monophosphates. The preferred substrate for YitU was shown to be the redox-active coenzyme FMN. Furthermore, the application of yitU overexpression for the design of industrially important RF- and AICAR-producing strains was demonstrated.

Materials and methods

Bacterial strains and plasmids

The bacterial strains and plasmids used in this study are shown in Table 1. The primers used in this study are shown in Supplementary Table S1. E. coli was used as a host for cloning and protein expression. The B. subtilis and B. amyloliquefaciens strains, except for strain AJ1991purH::spc, were constructed using pNZT1-based delivery plasmids and a two-step replacement recombination procedure (Zakataeva et al. 2010), as described in Table 1. Single crossover was maintained by erythromycin (Em) resistance. Strain AJ1991purH::spc, in which the spc cassette was inserted into purH, was constructed by allele replacement (due to double crossover events) using the delivery plasmid pHY300PLK-purH::Sp.

Table 1 Bacteria and plasmids used in this study

Growth conditions and preparation of crude cell extracts

E. coli and B. subtilis were grown in Luria-Bertani (LB) or M9 minimal medium (Miller 1972) supplemented with d-glucose (0.4% for E. coli or 2% for Bacillus unless otherwise specified). When required, thiamine HCl (5 μg/ml), RF (25 μg/ml), tryptophan (50 μg/ml), casamino acids (0.1% (w/v)), ampicillin (Ap, 100 μg/ml), erythromycin (Em, 200 μg/ml for E. coli or 10 μg/ml for Bacillus), kanamycin (Km, 10 μg/ml), tetracycline (Tc, 10 μg/ml), spectinomycin (Spc, 100 μg/ml), or chloramphenicol (Cm, 7 μg/ml) was added to the medium. Solid medium was obtained by adding 20 g/l agar to liquid medium. All reagents were purchased from Sigma-Aldrich (Steinheim, Germany) unless otherwise specified.

To select 5′-nucleotidase genes by the “shotgun” technique, recombinant plasmids containing DNA fragments from genomic libraries were transferred into E. coli strain GS72, and the resulting transformants were grown in glucose M9 minimal medium supplemented with inhibitory concentrations of guanosine (50 μg/ml) or inosine (1500 μg/ml).

In agar diffusion assays, drops of cellular suspensions of the B. subtilis 168 strain containing plasmids pMWAL1, pMWAL1-yitUBs, pMWAL1-yitUBa or pMWAL1-PyitUBa-yitUBs were placed onto M9 plates supplemented with glucose and tryptophan (without RF) on which a suspension of the RF auxotrophic strain B. subtilis 168 Δrib had previously been spread. After 16 h of cultivation at 37 °C, the diameters of the growth halos of B. subtilis 168 Δrib around the plaques of control strain harboring empty vector and yitU-overexpressing strains were assessed. All experiments were performed in triplicate.

Extracellular AICAR accumulation in AICAR-producing strains was evaluated by tube fermentation as previously described (Sheremet et al. 2011), but the initial glucose concentration in the fermentation media was 60 g/l. AICAR concentration in the culture broth was determined using high-performance liquid chromatography (HPLC) as described (Sheremet et al. 2011). Glucose concentrations were determined by an enzymatic method using an enzyme electrode (BIOSEN C-line; EKF Diagnostic, Germany). Bacterial growth was assayed by measuring the optical density of the culture broth (OD600) using a spectrophotometer (UV-1800, Shimadzu, Kyoto, Japan) at 600 nm.

Extracellular RF accumulation in RF-producing strains and BsC+-based strains was evaluated by flask fermentation. Cells were incubated on glucose medium plates for 18 h at 34 °C and then resuspended in 40 ml of fresh M9 medium supplemented with glucose (1% for RF-producing strains and 0.4% for BsC+-based strains) to an OD600 of 0.3 (for RF-producing strains) or 0.1 (for BsC+-based strains). Cm was added to plasmid-containing strains. Strains were incubated in 750-ml flasks at 34 °C in a rotary shaker for 72 h (for RF-producing strains) or 192 h (for BsC+-based strains). Every 24 h, samples were taken from each strain and analyzed for biomass accumulation (OD600) and RF and glucose concentrations.

RF concentrations in culture broth were determined using a UPLC Acquity system (Waters, USA) with a fluorescence detector. Samples (5 μl) of appropriately diluted cell-free supernatants were applied to a Nucleosil 100-5 C18 MPN column (4 × 125 mm, 5 μm; Macherey & Nagel). The following solvent system was used at a flow rate of 0.7 ml/min: 25% (vol/vol) acetonitrile–50 mM formic acid–50 mM ammonium formate (pH 4.3). Detection was carried out with a fluorescence detector (excitation, 325 nm; emission, 513 nm; Waters Associates, Inc., USA).

To analyze culture broth by liquid chromatography-tandem mass spectrometry (LC-MS/MS), cells were grown for 70 h in 20 ml of M9 medium supplemented with 0.2% glucose and Cm in a rotary shaker in 750-ml flasks. For LC-MS/MS analysis, cell-free supernatants of the culture broth were used.

To prepare crude cell extracts, cells grown with aeration to mid-log phase in LB or M9 medium (E. coli) and M9 medium (Bacillus) supplemented with thiamine HCl and Ap for E. coli or tryptophan, casamino acids and Cm (when required) for Bacillus were harvested by centrifugation, washed with 0.9% NaCl, resuspended in 0.7 ml of buffer (50 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 10% glycerol, 1 mM AEBSF), and then lysed by sonication (3× 60 s), following which debris was removed by centrifugation at 13.200×g for 20 min at 4 °C. The protein concentration in the crude extract was 3 mg/ml.

DNA manipulation and genetic methods

All recombinant DNA manipulation was conducted according to standard procedures (Sambrook and Russell 2001) and the recommendations of the enzyme manufacturer (Thermo Scientific, Lithuania, Vilnius). Plasmid and chromosomal DNA was isolated using the Qiagen Miniprep kit (Germany, Hilden) and Qiagen DNA purification kit (Germany, Hilden), respectively, according to the manufacturer’s instructions.

Transformation of B. subtilis competent cells, E40 bacteriophage transduction to transfer plasmids into B. amyloliquefaciens cells, PCR amplification, and DNA sequence analyses were performed as previously described (Zakataeva et al. 2010). Primers were purchased from Evrogen (Moscow, Russia). All constructs were verified by DNA sequencing.

Heterologous expression of YitU and purification

The pET15-H6-yitUBs expression construct was transferred into E. coli BL21(DE3). The recombinant hexahistidine-tagged YitUBs (Ht-YitUBs) protein was overexpressed in the obtained transformants as previously described (Zakataeva et al. 2016) and purified by immobilized metal affinity chromatography on a HisTrap HP column (GE Healthcare) according to the manufacturer’s instructions. Imidazole-eluted recombinant protein was transferred to buffer A (50 mM Tris-HCl buffer, pH 7.1, 5 mM MgCl2, 20% glycerol) by gel filtration on a Sephadex G-25 column (Pharmacia) and stored at − 70 °C until required. The protein concentration was assayed using a Bio-Rad protein assay kit (Bio-Rad) with bovine serum albumin as a standard. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed using 15% polyacrylamide gels and subsequent staining with Coomassie brilliant blue R250.

Gel filtration analysis was performed on a Superose 6 Increase 10/300 GL column (GE Healthcare Life Sciences) in PBS (10 mM phosphate buffer, 140 mM NaCl, pH 7.4) according to the manufacturer’s recommendation. The column was calibrated using a sample from a molecular mass standard kit (Gel Filtration Markers Kit for Protein Molecular Weights 29,000–700,000 Da, Sigma-Aldrich, St. Louis, USA).

Enzymatic assay

General phosphodiesterase activity was measured spectrophotometrically at 25 °C in a reaction mixture (0.5 ml) containing 50 mM Tricine buffer (pH 8.5), 0.5–5 mM Me2+ (Mg2+ or Mn2+), 5 mM bis(p-nitrophenyl) phosphate (bis-pNPP) or 5 mM p-nitrophenyl phosphorylcholine (pNPPC) as a substrate and purified Ht-YitUBs (3 μg) diluted in a stabilization buffer (50 mM Tris-HCl buffer, pH 7.0, 5 mM MgCl2, 20% glycerol, 1 mg/ml BSA). The reaction was initiated by substrate addition, and p-nitrophenol (pNP) production was monitored at 410 nm (ε410 nm = 15,460 M−1 cm−1). The specific phosphodiesterase activity towards 1 mM flavin adenine dinucleotide (FAD) was assessed using shrimp alkaline phosphatase as an auxiliary enzyme as previously described (Podzelinska et al. 2009).

General phosphatase activity towards the artificial substrate pNPP (pNPPase) was assayed spectrophotometrically at 25 °C. The standard reaction mixture (0.5 ml) contained 50 mM imidazole buffer, pH 7.0, 5 mM MgCl2, 10 mM pNPP, and purified Ht-YitUBs (3 μg) or crude cell extract (0.1 mg of total protein). The reaction was initiated by the addition of pNPP and monitored by continuously following the production of pNP at 410 nm. No activity was detected in the control reaction, which excluded the enzyme.

Specific phosphatase (5′-nucleotidase) activity towards physiological substrates was assayed by the rate of inorganic phosphate (Pi) release. A standard reaction mixture (0.5 ml) contained 50 mM imidazole buffer, pH 7.0, 5 mM MgCl2, 3 mM or 15 mM substrate for purified Ht-YitUBs (from 0.08 to 3 μg), and crude cell extract (0.1 mg of total protein), respectively. The assay was initiated by substrate addition and carried out at 30 °C for 10 min. The reaction rate was linear under these conditions. The amount of released inorganic phosphate (Pi) was assessed by a previously described colorimetric method (Chen et al. 1956). For acid-labile substrates (all di- and triphosphates, sugar phosphates, NADP, pyridoxal 5-phosphate, phosphonoacetic acid, phosphoenolpyruvate, PRPP), Pi was assessed by the method of Cariani (Cariani et al. 2004). Pi concentrations were estimated from a standard curve obtained with KH2PO4. To exclude the influence of nonenzymatic factors, the background phosphate level was monitored in parallel using a control reaction without enzyme. The activity was calculated by subtracting nonspecific substrate hydrolysis measured in the absence of protein, which was no more than 5% of the total activity. One unit of activity was defined as 1 μmol of Pi released per minute at 30 °C.

The pH dependence of the phosphatase activity towards pNPP (10 mM) or 5’-GMP (3 mM) was determined in the presence of 5 mM MgCl2 and purified Ht-YitUBs. The assays were performed in the following buffer systems (50 mM): MES buffer between pH 5.5 and 6.5, imidazole buffer between pH 6.0 and 7.5, Tris-HCl buffer between pH 7.1 and 8.9, and CHES buffer between pH 9 and 9.5.

The metal dependence of the phosphatase activity of purified Ht-YitUBs towards pNPP (10 mM) or 5’-IMP (3 mM) was determined in 50 mM imidazole buffer, pH 7.0, using various divalent metal ions (Mg2+, Mn2+, Co2+, Ni2+).

To determine the Michaelis constant (Km) and maximal initial velocity (Vmax), kinetic analyses were performed using the appropriate activity assay with at least ten different concentrations of substrate in the range of 0 to 20 mM for nucleotides and 0 to 3 mM for FMN. The measured activities were analyzed using the Lineweaver–Burk plot or Hill plot (for AICAR-P) with the nonlinear curve-fitting program GraphPad Prism 8 software (GraphPad Software, Inc., San Diego, CA, USA). All kcat values correspond to the turnover number per monomer. All kinetic parameters were obtained from at least three measurements.

LC-MS/MS analysis

Detection of RF in samples was performed by LC-MS/MS using an Acquity system with a Xevo TQD mass detector (Waters) and a previously described method (Guo et al. 2006) with the following modifications. Chromatographic separation was achieved with an Acquity UPLC BEH C18 (1.7 μ, 2.1 × 100 mm) column. UPLC conditions were set as follows: column temperature 30 °C, λ = 222 nm, injection volume 5 μl, flow rate 0.3 ml/min, buffers: [A], 5%, and [B], 95% methanol in water. The gradient was as follows: [B] was increased from 5 to 70% over 10 min, then held for 2 min at 70%, decreased to 5% over 0.5 min and held for 2.5 min at 5%. The MS/MS conditions were as follows: electrospray ionization (ESI), positive ion mode, multiple reaction monitoring mode, capillary voltage 3.5 kV, desolvation temperature 600 °C, source gas flow 800 L/H, cone gas flow 3 L/H, source temperature 150 °C, cone voltage 32 V, and collision energy 25 V. The precursor-to-product ion transitions m/z 377 →m/z 243, m/z 377 → m/z 198, m/z 377 → m/z 172, m/z 377 → m/z 117, and m/z 377 → m/z 99 were used for quantification. Standards were prepared by dissolving RF in Milli-Q water. The calibration range for the mass spectrometer was from 45 to 4500 μg/l. The limit of detection was 10 μg/l.

Statistical analysis

Statistical analyses were performed using GraphPad Prism version 8 (GraphPad Software, San Diego, CA, USA). One-way ANOVA and Tukey’s multiple-comparison test were used to determine significant differences among sample means. Tests were considered to be statistically significant if P values lower than 0.05 were obtained.

Results

Search for B. subtilis 5′-nucleotidases using the selection of clones resistant to purine nucleosides

To identify genes encoding 5′-nucleotidases in Bacillus species, a method to exploit the hydrolytic dephosphorylation activity of the gene products was applied. This method was based on “shotgun” cloning followed by the direct selection of DNA fragments containing 5′-nucleotidase genes identified by the resistance of recombinant E. coli cells to the purine nucleosides guanosine and inosine at inhibitory concentrations.

The uptake of extracellular nucleosides at even high concentrations is not toxic for wild-type E. coli cells (Petersen 1999). However, the phosphorylation of intracellular guanosine (inosine) catalyzed by guanosine-inosine kinase (EC 2.7.1.73) encoded by the gsk gene leads to the formation of GMP (IMP) (Fig. S1). GMP is further converted to IMP, AMP, and ADP, which, at high concentrations, inhibit the activity of 5-phosphoribosyl-1-pyrophosphate (PRPP) synthetase (Willemoës et al. 2002), resulting in PRPP deficiency and growth arrest (Petersen 1999). Proper functioning of PRPP synthetase is essential for life because PRPP is the biosynthetic precursor of the amino acids histidine and tryptophan, as well as purine, pyrimidine, and pyridine (NAD+, NADP+) nucleotides. Growth arrest is prevented in wild-type E. coli cells by the degradation of guanosine (inosine) to guanine (hypoxanthine) and ribose-1-phosphate (catalyzed by purine nucleoside phosphorylase encoded by deoD) and feedback inhibition of guanosine-inosine kinase activity by GMP (Fig. S1). However, the addition of guanosine (inosine) to the growth medium of E. coli cells incapable of purine nucleoside cleavage (ΔdeoD) and expressing feedback-resistant guanosine kinase (due to a gsk-3 mutation) caused an uncontrolled increase in intracellular GMP (IMP) and then AMP/ADP pools, followed by PRPP synthetase inhibition and growth arrest (Petersen 1999). Based on these data, we hypothesized that the dephosphorylation of excess nucleotides via 5′-nucleotidase gene overexpression in the gsk-3 ΔdeoD strain would remove PRPP synthetase inhibition and rescue sensitivity to the purine nucleosides guanosine and inosine.

Therefore, to find genes encoding enzymes with 5′-nucleotidase activity in B. subtilis and B. amyloliquefaciens, genomic libraries for the B. subtilis Bs∆DEG (168 ∆deoD ΔpbuE ΔpupG) and B. amyloliquefaciens IAM∆DG (IAM1523 deoD::Km, pupG::Cm) strains were first obtained. Both strains contain deletions of purine nucleoside phosphorylase genes (unlike E. coli, these bacteria have two purine nucleoside phosphorylase genes, deoD and pupG) to exclude the selection of these genes in this search. Then, genomic DNA was digested with EcoRI and ligated to the EcoRI-digested low copy number vector pMW118 to obtain recombinant plasmids for the expression of cloned genes controlled by their own regulatory elements. The resulting recombinant plasmids containing DNA fragments from the genomic libraries were transferred into E. coli strain GS72 (TG1 ΔdeoD gsk-3), which is sensitive to purine nucleosides due to deoD and gsk-3 mutations, to select clones resistant to guanosine (50 μg/ml) and inosine (1500 μg/ml) at inhibitory concentrations. More than 50 plasmids in which DNA fragments ranging in size from 1600 to 6000 bp had been inserted were selected. These insertions were identified by sequence analysis, followed by an NCBI database sequence similarity search (Altschul et al. 1990). Plasmids conferring the highest level of resistance to purine nucleosides that simultaneously contained open reading frames (ORFs) encoding putative phosphatases were selected for further investigation. Identification of genes responsible for the resistance phenotype revealed the B. subtilis and B. amyloliquefaciens yutU genes (yitUBs and yitUBa, respectively), which encode putative phosphatases. These genes were recloned into the low copy number E. coli/B. subtilis shuttle vector, pMWAL1, under the control of their own regulatory elements, yielding the plasmids pMWAL1-yitUBa and pMWAL1-yitUBs, respectively. Resistance to inosine and guanosine conferred upon GS72 cells by these plasmids was confirmed (Supplementary Table S2). Moreover, pMWAL1-yitUBa and pMWAL1-yitUBs were also found to increase resistance to the purine analog 2,6-diaminopurine (DAP) (Supplementary Table S2).

In silico analysis of the 5′-untranslated regions (UTRs) of yitUBs and yitUBa did not reveal sequences that exactly matched consensus sequences from known SigA promoters. However, according to published data (Nicolas et al. 2012), B. subtilis yitU is transcribed from the SigA promoter as part of a tricistronic transcript that also includes the downstream ORFs BSU_11136 and yizC, both of which have unknown functions (Supplementary Fig. S2). Indeed, no putative Rho-independent transcription terminators immediately downstream of the yitU ORF were predicted using the ARNold: finding terminators web server (http://rna.igmors.u-psud.fr/toolbox/arnold/index.php). Based on low-level matching with the optimum consensus sequence of the identified yitU promoter, moderate expression of this gene, at least during exponential growth, was suggested. The UTRs of yitUBs and yitUBa demonstrated differences in their promoter and Shine–Dalgarno (SD) sequences, suggesting that these genes are expressed at different levels (Supplementary Fig. S3). Indeed, the pMWAL1-yitUBs and pMWAL1-yitUBa plasmids, in which yitUBs and yitUBa, respectively, are expressed under the control of their own regulatory elements, conferred different levels of resistance to purine nucleosides and DAP to GS72 cells (Supplementary Table S2). Moreover, pMWAL1-PyitUBa-yitUBs, which contained a DNA fragment in which the coding region of yitUBs was placed under control of the yitUBa UTR, conferred a higher level of resistance than pMWAL1-yitUBs.

When the yitU gene was identified in our previous study (Yusupova et al. 2014), the yitU product was annotated in the NCBI protein database (http://www.ncbi.nlm.nih.gov/protein) as a putative phosphatase and assigned to the Cof-type HAD-IIB subfamily of the HADSF and Cluster of Orthologous Groups of proteins (COG) no. 0561 (hydroxymethylpyrimidine pyrophosphatase and other HAD family phosphatases, ftp://ftp.ncbi.nih.gov/pub/COG/COG2014/static/byCOG/COG0561.html) due to the presence of specific domains and its similarity with E. coli Cof hydrolase. The yitUBs and yitUBa genes possess a high nucleotide sequence similarity of 75.2%. The translated YitUBs and YitUBa proteins have 78.9% identical and 87.0% similar amino acid residues (Supplementary Fig. S4), suggesting an identical function for the YitUBs and YitUBa proteins.

Heterologous expression and purification of YitUBs

To characterize the biochemical properties of YitU, two variants of yitUBs (to translate YitUBs in its native form and as an N-terminally hexahistidine-tagged protein) were cloned into the expression vector pET15b(+), yielding the expression plasmids pET15-yitUBs and pET15-H6-yitUBs, respectively. After the introduction of these plasmids into E. coli strain BL21(DE3), both proteins were produced in a soluble form. The electrophoretic patterns of total extracted proteins by SDS-PAGE revealed protein bands with molecular masses of approximately 30 kDa, which was consistent with the predicted molecular masses of YitUBs and Ht-YitUBs (30.6 and 31.9 kDa, respectively). Moreover, these bands were not detected in the control strain, which contained empty pET15b(+) vector (Supplementary Fig. S5).

pNPPase activity towards the artificial substrate pNPP was assayed in BL21(DE3) (pET15b(+)), BL21(DE3) (pET15-yitUBs) and BL21(DE3) (pET15-H6-yitUBs) crude cell extracts (Fig. 1). YitUBs was shown to possess pNPPase activity. Moreover, the histidine tag at its N-terminus did not alter this activity. Therefore, further study was performed with the purified recombinant Ht-YitUBs protein.

Fig. 1
figure1

pNPPase activity in E. coli BL21(DE3) strains harboring empty vector (pET15b(+)) or plasmids with native yitUBs (pET15-yitUBs) and N-terminally hexahistidine-tagged yitUBs (pET15-H6-yitUBs). The results are expressed as the means of three independent experiments, and error bars indicate standard deviations

The recombinant enzyme was purified to near homogeneity from the supernatant of disrupted BL21(DE3) (pET15-H6-yitUBs) cells using immobilized metal affinity chromatography (Supplementary Fig. S5).

The Ht-YitUBs subunit structure was analyzed by gel filtration. The protein eluted as a single symmetric peak with a retention time that corresponded to a molecular mass of approximately 32 ± 5 kDa, suggesting that the active form of the enzyme is monomeric (Supplementary Fig. S6).

Biochemical characterization of recombinant Ht-YitUBs

General phosphatase screening with respect to artificial chromogenic substrates demonstrated that Ht-YitUBs has no activity towards bis-pNPP and pNPPC (contrary to pNPP), suggesting the absence of phosphodiesterase activity. The optimum pH for Ht-YitUBs was estimated to be 7.0 in 50 mM imidazole buffer with pNPP and GMP as artificial and physiological substrates, respectively (Supplementary Fig. S7). Similar to other members of the HADSF, Ht-YitUBs absolutely requires Mg2+ for its activity. The optimal concentration of Mg2+ was shown to be 5 mM (Supplementary Fig. S8). A maximum pNPPase activity of 160 nmol/mg min was observed in imidazole buffer, pH 7.0, in the presence of 5 mM MgCl2.

Under optimal conditions, the phosphatase activity of purified Ht-YitUBs with respect to a wide spectrum of physiological substrates (deoxyribo- and ribonucleoside tri-, di-, and monophosphates; sugar phosphates; and other phosphorylated metabolites) was evaluated as described in the “Materials and methods” section. Ht-YitUBs demonstrated the highest activity towards deoxyribo- and ribonucleoside monophosphates (Table 2). FMN, dAMP, GMP, dGMP, CMP, AMP, XMP, IMP, and AICAR-P proved to be its preferred substrates.

Table 2 Activity of purified Ht-YitUBs towards various substrates

The kinetic parameters with FMN, dAMP, GMP, dGMP, CMP, AMP, XMP, IMP, and AICAR-P were studied (Table 3). Ht-YitUBs was shown to have low substrate specificity (Km values in the mM concentration range) and modest catalytic efficiencies with respect to all tested substrates except for FMN, for which the Michaelis constant was almost three orders of magnitude lower, and the catalytic efficiency was two orders of magnitude higher than those of the other tested substrates. The kinetic behavior of the enzyme in the hydrolysis of the tested substrates, except AICAR-P, followed Michaelis-Menten kinetics. For AICAR-P, the kinetic curve indicated allosterism with a Hill coefficient of 1.83 ± 0.15.

Table 3 Kinetic parameters of Ht-YitU for its preferred substrates

Overexpression of yitU increased the extracellular accumulation of RF by wild-type B. subtilis

Inactivation of yitU in the chromosome of the wild-type B. subtilis strain, BsC+ (B. subtilis 168 trpC+), had essentially no effect on cell growth and the glucose consumption rate during its cultivation in minimal medium (Supplementary Fig. S9). When the expression plasmids pMWAL1-yitUBs, pMWAL1-yitUBa, and pMWAL1-PyitUBa-yitUBs or the empty vector pMWAL1 were transferred into BsC+, the resulting transformants were cultivated in minimal medium, and the culture broth of cells overexpressing yitU developed a yellow-green color (Fig. 2a). Moreover, the intensity of the color depended on the type of the yitU expression plasmid and was most intense in the case of the pMWAL1-PyitUBa-yitUBs plasmid. Comparison of the 5′-nucleotidase activities in BS168 ∆yutF harboring pMWAL1, pMWAL1-yitUBs, pMWAL1-yitUBa, and pMWAL1-PyitUBa-yitUBs showed that pMWAL1-PyitUBa-yitUBs conferred the highest level of activity, suggesting the highest level of yitU expression due to the 5’ UTR of the B. amyloliquefaciens gene (Fig. 3). The BS168 ∆yutF strain, in which another 5′-nucleotidase gene, yutF, was disrupted, was used in this assay to exclude the impact of yutF on 5′-nucleotidase activity. Interestingly, we observed a more intense yellow-green color with BS168 ∆yutF (pMWAL1-PyitUBa-yitUBs) than with the BsC+ (pMWAL1-PyitUBa-yitUBs) strain (Fig. 2c vs Fig. 2a).

Fig. 2
figure2

Effect of yitU overexpression on the accumulation of colored compounds in culture broth. a, b BsC+ derivatives: (1) BsC+, (2) BsC+∆U, (3) BsC+ (pMWAL1), (4) BsC+ (pMWAL1-yitUBs), (5) BsC+ (pMWAL1-yitUBa), (6) BsC+ (pMWAL1-PyitUBa-yitUBs). c, d BS168 ∆yutF derivatives: (1) BS168 ∆yutF, (2) BS168 ∆yutF (pMWAL1), (3) BS168 ∆yutF (pMWAL1-yitUBs), (4) BS168 ∆yutF (pMWAL1-yitUBa), (5) BS168 ∆yutF (pMWAL1-PyitUBa-yitUBs). b, d The photo was captured under UV light

Fig. 3
figure3

5’-Nucleotidase activity towards 15 mM IMP in B. subtilis strains overexpressing yitUBs and yitUBa. The values are the means ± standard deviations of three independent experiments

Since FMN is the preferred substrate of YitU, we supposed that the colored compound that accumulated in the culture broth is the product of FMN dephosphorylation, RF. Consistent with this suggestion, fluorescence of the colored culture broth was observed under UV light (Fig. 2b, d). Moreover, agar diffusion assays demonstrated that an RF auxotrophic strain, B. subtilis 168 Δrib, formed halos of growth around cells containing the pMWAL1-yitUBs, pMWAL1-yitUBa, and pMWAL1-PyitUBa-yitUBs plasmids expressing yitU, most likely due to RF feeding (Fig. 4). Indeed, LC-MS/MS analysis of cell-free culture broth supernatants of BsC+ bearing the empty vector, pMWAL1, or the pMWAL1-PyitUBa-yitUBs plasmid confirmed the presence of RF (Supplementary Fig. S10). Moreover, the RF concentration in the strain overexpressing yitU was 20 times higher than that in the strain harboring empty vector (2 mg/l vs 0.1 mg/l, respectively).

Fig. 4
figure4

Agar diffusion assay. Halos of growth of the RF auxotrophic strain B. subtilis 168 Δrib around plaques of the following strains: (1) BS168 ∆yutF, (2) BS168 ΔyutF ΔU, (3) BS168 ∆yutF (pMWAL1), (4) BS168 ∆yutF (pMWAL1-yitUBs), (5) BS168 ∆yutF (pMWAL1-yitUBa), (6) BS168 (∆yutF pMWAL1-PyitUBa-yitUBs)

The kinetics of RF accumulation in the culture broths of BsC+ cells in which yitU was disrupted or overexpressed were studied. In this experiment, the BsC+ strain and its ∆yitU derivative did not accumulate RF at detectable levels (Fig. 5, Supplementary Table S3). Derivatives of BsC+ harboring the pMWAL1-yitUBs, pMWAL1-yitUBa, and pMWAL1-PyitUBa-yitUBs plasmids accumulated in culture broths from 1 to 5 mg/l RF. The plasmid expression of yitUBs under control of the yitUBa promoter region (pMWAL1-PyitUBa-yitUBs) led to a nearly fivefold increase in RF accumulation compared with the plasmid expression of yitUBs under native regulation (pMWAL1-yitUBs).

Fig. 5
figure5

Extracellular RF accumulation in B. subtilis BsC+ harboring pMWAL1-yitUBs, pMWAL1-yitUBa, and pMWAL1-PyitUBa-yitUBs. The values are the means ± standard deviations of three independent experiments. Some error bars are smaller than the data point icons

Disruption of yitU decreased, while enhancement of yitU expression increased, RF accumulation in an RF-producing strain

To further investigate the influence of yitU on RF production, the gene was disrupted and overexpressed in an RF-producing strain. B. subtilis Y25 can produce RF due to the increased expression of purine biosynthetic genes, overexpression of rib operon genes and deficiency of RF kinase activity (ribC1). This strain was obtained by the traditional selection of clones resistant to the purine analog 8-azaguanine and the RF analog roseoflavin (Mironov et al. 2002). Inactivation of yitU in strain Y25 reduced both RF accumulation and the glucose consumption rate at the productive phase but slightly increased the accumulated biomass (Fig. 6a, b). In contrast, yitU expression from plasmids pMWAL1-yitUBs and pMWAL1-yitUBa increased RF accumulation and slightly enhanced glucose consumption in strain Y25 at the productive phase (Fig. 6c, d).

Fig. 6
figure6

Influence of yitUBs deletion (a, b) and overexpression (c, d) on cell growth, glucose consumption (a, c), and extracellular accumulation of RF (b, d) in RF-producing B. subtilis strain Y25. Solid lines indicate growth (a, c) and RF accumulation (b, d), while dashed lines indicate glucose consumption (a, c). The values are the means ± standard deviations of three independent experiments. Some error bars are smaller than the data point icons

Disruption of yitU decreased, while enhancement of yitU expression increased, AICAR accumulation in an AICAR-producing strain

Since we observed the specific behavior of Ht-YitUBs in AICAR-P hydrolysis, the effect of yitU disruption and overexpression on the performance of an AICAR-producing strain was studied. Strain AJ1991purH::spc can produce AICAR due to enhanced de novo purine biosynthesis and the blockade of the conversion of AICAR-P to IMP. Several derivatives of AJ1991purH::spc have been constructed. First, yitU was disrupted in the chromosome of AJ1991purH::spc, yielding strain AJΔU. The yitU overexpression plasmids pMWAL1-yitUBs and pMWAL1-yitUBa and the empty vector pMWAL1 (used as a control) were transferred into AJ1991purH::spc and AJΔU. The resulting strains were tested by test tube fermentation to evaluate the kinetics of cell growth, glucose consumption, and AICAR accumulation (Fig. 7). yitU deletion in AJ1991purH::spc had essentially no effect on cell growth but drastically decreased the glucose consumption rate and AICAR production (Fig. 7a, b).

Fig. 7
figure7

Influence of yitUBa deletion (a, b) and overexpression (c, d) on cell growth, glucose consumption (a, c), and extracellular accumulation of AICAR (b, d) in the B. amyloliquefaciens AICAR-producing strain AJ1991purH::spc. Solid lines indicate growth (a, c) and AICAR accumulation (b, d), while dashed lines indicate glucose consumption (a, c). The values are the means ± standard deviations of three independent experiments. Some error bars are smaller than the data point icons

yitUBa overexpression in AJΔU restored AICAR accumulation, which was lost in this strain due to yitU disruption (Fig. 7d). Moreover, compared with the control strain AJ1991purH::spc (pMWAL1), strain overexpressing yitUBa (AJ1991purH::spc (pMWAL1-yitUBa)) demonstrated 1.6-fold increase in AICAR accumulation (Fig. 7d), less accumulated biomass, which nevertheless did not lead to a reduction in the glucose consumption rate (Fig. 7c) most likely due to more active product biosynthesis. The same effects on growth, glucose consumption, and AICAR accumulation were observed in AJ1991purH::spc and AJΔU due to yitUBs expression from pMWAL1-yitUBs (Supplementary Table S4, Supplementary Fig. S11).

Discussion

Despite the important role of 5′-nucleotidases in cellular metabolism, only a few of these enzymes have been characterized in the gram-positive bacteria B. subtilis and B. amyloliquefaciens, the workhorses among industrial microorganisms. To identify genes encoding 5′-nucleotidases in Bacillus species, a search for genes homologous to earlier characterized 5′-nucleotidase genes in other bacteria, for example, E. coli, is often used as a suitable tool (Terakawa et al. 2016; Zakataeva et al. 2016). In this study, another method exploiting 5′-nucleotidase activity in gene products was applied. This method was based on “shotgun” cloning followed by the direct selection of DNA fragments containing 5′-nucleotidase genes due to the resistance of recombinant E. coli GS72 (TG1 deoD gsk-3) cells to the purine nucleosides guanosine and inosine at inhibitory concentrations.

Using this strategy, orthologous yitU genes were selected from genomic libraries of B. subtilis and B. amyloliquefaciens strains. Their products belong to the HADSF and have a high sequence similarity of 87%, suggesting the identical functions of these proteins. The B. subtilis yitU gene was produced in E. coli as an N-terminal hexahistidine-tagged protein, purified, and biochemically characterized as a soluble 5′-nucleotidase with a broad substrate specificity. Like many 5′-nucleotidases of the HADSF, YitU can dephosphorylate a wide range of substrates, including deoxyribo- and ribonucleotides. Among these compounds, the enzyme has the highest catalytic efficiency with respect to the monophosphates dAMP, GMP, dGMP, CMP, AMP, XMP, IMP, and AICAR-P. However, the preferred substrate with a Michaelis constant almost three orders of magnitude lower than the Km values for the listed monophosphates was shown to be FMN (Km = 0.096 mM). While this work was in progress, Sarge and coauthors reported that the products of the B. subtilis genes ycsE, ywtE, and yitU catalyze the dephosphorylation of ARPP (designated as 6 in the original publication) with high catalytic efficiency, forming the pyrimidine precursor of RF, 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione (Sarge et al. 2015). The relatively high specific activities of YcsE, YwtE, and YitU towards FMN were also demonstrated (Sarge et al. 2015). In our experiments, we did not study the activity and kinetic characteristics of Ht-YitUBs towards ARPP due to the commercial inaccessibility of this compound and instead used data obtained by Sarge and coauthors for comparison. We found that although the Michaelis constants for ARPP and FMN were approximately the same, the catalytic constant (kcat) and catalytic efficiency (kcat/Km) of the enzyme for FMN were considerably higher than those for ARPP (Table 3). While Sarge and coauthors did not report the kinetic parameters for YitU with respect to FMN as a substrate, their data on the specific activity of purified YitU towards this compound are consistent with the value we report here (Table 2).

The expression of several enzymes (YcsE, YwtE, and YitU) with substrate specificity towards ARPP and FMN but different affinities for each of these substrates in B. subtilis might be necessary for fine-tuning cellular pools of the important flavins RF, FMN, and FAD. The main derivatives of RF, FMN and FAD, are redox-active coenzymes that associate with proteins to form flavoproteins. Flavoproteins function in a large variety of metabolic pathways, including electron transport, DNA repair, nucleotide biosynthesis, the synthesis of cofactors and heme groups, the β-oxidation of fatty acids, and amino acid catabolism (Abbas and Sibirny 2011). The role of flavoproteins in cellular redox metabolism is ensured by the ability of flavins to transfer electrons. Importantly, unlike other electron transfer cofactors, flavins can mediate both one-electron and two-electron transfer processes (Edwards 2014), making them one of the most important types of cofactors in cells. The intracellular concentrations, composition, and ratios of free flavins should be strongly regulated. FMN controls the biosynthesis and transport of RF by regulating related genes at the level of transcription or translation through a riboswitch mechanism (Gelfand et al. 1999; Winkler et al. 2002). YcsE, YwtE, and YitU, phosphatases with different flavin specificities, most likely exert their regulatory effects in conjunction with another enzyme involved in the conversion of RF to FMN and FMN to FAD, bifunctional flavokinase/flavin adenine dinucleotide synthetase (encoded in B. subtilis and B. amyloliquefaciens by ribC) (Mack et al. 1998).

ARPP dephosphorylation is commonly assumed not to be a bottleneck in RF production even in industrial producers that strongly overexpress other RF biosynthetic genes (Hümbelin et al. 1999; Perkins et al. 1999). In this study, we have shown that enhanced activity of the 5′-nucleotidase YitU in B. subtilis not only further elevated RF production in the RF-producing strain Y25 but also significantly increased RF accumulation in the wild-type strain BsC+, making it an RF producer. The positive effect of yitU overexpression on RF production can be attributed to at least two factors: enhanced de novo RF synthesis due to activation of one of its steps (ARPP dephosphorylation) and the enhanced conversion of FMN to RF, leading to a reduction in the FMN pool and thus upregulating RF biosynthesis.

Interestingly, the pMWAL1-PyitUBa-yitUBs plasmid, which was shown to support the highest level of YitU activity, led to the severe retardation of Y25 (pMWAL1-PyitUBa-yitUBs) growth (data not shown), most likely due to a drastic deficiency in the redox-active cofactors FMN and FAD caused by the simultaneously impaired activity of bifunctional RF kinase/FMN adenylyltransferase (ribC1) and enhanced activity of FMN hydrolase. In contrast, the disruption of yitU in the chromosome of the Y25 strain reduced RF accumulation but increased cell growth, most likely due to a decrease in the conversion of FMN to RF, making FMN and FAD more available for various flavoproteins that catalyze important redox reactions in metabolism. In this study, we did not investigate the reason for increased RF accumulation due to yitU overexpression under the genetic background in which another 5′-nucleotidase gene, yutF, was deleted. The elimination of YutF function may have reduced the hydrolysis of some phosphorylated metabolites involved in RF biosynthesis.

AICAR-P, an intermediate in the purine nucleotide biosynthetic pathway and a byproduct of histidine biosynthesis, is a natural analog of AMP and a very important regulatory compound in bacteria, yeast, and humans. By both direct and indirect mechanisms, AICAR-P affects the biosynthesis of purines, thiamine, and histidine as well as one-carbon, carbohydrate, and lipid metabolism (Hürlimann et al. 2011; Daignan-Fornier and Pinson 2012; Bazurto et al. 2015; Ducker and Rabinowitz 2015; Malykh et al. 2018). In our study of the kinetic parameters of recombinant YitU, contrary to hydrolysis of the other tested substrates, which followed Michaelis-Menten kinetics, the kinetics of AICAR-P hydrolysis exhibited a sigmoidal behavior with a Hill coefficient of 1.83 ± 0.15, indicating positive cooperation. Gel filtration experiments showed that the active form of the enzyme is a monomer. Although cooperativity is traditionally observed in enzymes with multiple ligand-binding sites and/or multimeric assemblies, a few monomeric enzymes with single ligand-binding sites that display cooperativity have been described (Porter and Miller 2012). For example, among such enzymes is the best-studied mammalian glucokinase, which demonstrated a special type of allosteric regulation in which cooperativity was observed due to the rates of substrate transformation associated exclusively with conformational reorganization that occurs during substrate association (Storer and Cornish-Bowden 1976; Larion and Miller 2012).

The Km value of YitU for AICAR-P as a substrate is in the millimolar concentration range and significantly higher than the physiological concentrations of AICAR-P (from 1.6 to 21.8 μM in exponentially grown yeast cells (Daignan-Fornier and Pinson 2012)). Therefore, YitU might hydrolyze AICAR-P under conditions in which this metabolite is oversynthesized. Moreover, positive cooperativity of the enzyme during AICAR-P hydrolysis could allow the cell to adapt to conditions in which the AICAR-P pool sharply increases. Indeed, in strain AJ1991purH::spc, in which the de novo purine biosynthetic pathway is enhanced and the conversion of AICAR-P to IMP is blocked, the plasmid expression of both B. subtilis and B. amyloliquefaciens yitU resulted in the increased accumulation of the product of AICAR-P hydrolysis, AICAR. The disruption of yitU in the chromosome of the AICAR producer AJ1991purH::spc had essentially no effect on cell growth but led to a decrease in AICAR production. This effect can be explained by the inhibition of purine biosynthesis by the drastically increased AICAR-P pool and supports the suggestion that YitU in B. amyloliquefaciens possesses major AICAR-P dephosphorylation activity.

To summarize, in this study, a new approach was used to search for 5′-nucleotidase genes, following which the yitU gene was selected. The product of this gene belongs to the HADSF and not only exhibits specificity for a wide spectrum of deoxyribo- and ribonucleoside monophosphates but also is involved in de novo (Sarge et al. 2015) and salvage RF biosynthesis (from FMN) pathways. Due to its ability to dephosphorylate the important redox-active cofactor FMN and an AMP analog with multiple regulatory functions, AICAR-P, YitU is involved in regulating cellular metabolism. It was also demonstrated for the first time that the overexpression of yitU can be successfully applied to breed highly performing RF- and AICAR-producing strains.

References

  1. Abbas CA, Sibirny AA (2011) Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers. Microbiol Mol Biol Rev 75(2):321–360. https://doi.org/10.1128/MMBR.00030-10

  2. Abriouel H, Franz CM, Ben Omar N, Gálvez A (2011) Diversity and applications of Bacillus bacteriocins. FEMS Microbiol 35(1):201–232. https://doi.org/10.1111/j.1574-6976.2010.00244.x

  3. Altschul SF, Gish W, Miller W, Myers E.W, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215(3):403–410

  4. Asahara T, Mori Y, Zakataeva NP, Livshits VA, Yoshida K, Matsuno K (2010) Accumulation of gene-targeted Bacillus subtilis mutations that enhance fermentative inosine production. Appl Microbiol Biotechnol 87(6):2195–2207. https://doi.org/10.1007/s00253-010-2646-8

  5. Bazurto JV, Heitman NJ, Downs DM (2015) Aminoimidazole carboxamide ribotide exerts opposing effects on thiamine synthesis in Salmonella enterica. J Bacteriol 197(17):2821–2830. https://doi.org/10.1128/JB.00282-15

  6. Bianchi V, Spychala J (2003) Mammalian 5′-nucleotidases. J Biol Chem 278(47):46195–46198. https://doi.org/10.1074/jbc.R300032200

  7. Blatny JM, Brautaset T, Winther-Larsen HC, Haugan K, Valla S (1997) Construction and use of a versatile set of broad-host-range cloning and expression vectors based on the RK2 replicon. Appl Environ Microbiol 63(2):370–379

  8. Borowiec A, Lechward K, Tkacz-Stachowska K, Składanowski AC (2006) Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5′-nucleotidases. Acta Biochim Pol 53(2):269–278

  9. Cariani L, Thomas L, Brito J, del Castilloa JR (2004) Bismuth citrate in the quantification of inorganic phosphate and its utility in the determination of membrane-bound phosphatases. Anal Biochem 324(1):79–83

  10. Chen PS, Toribara TY, Warner H (1956) Microdetermination of phosphorus. Anal Chem 23:1756–1758

  11. Daignan-Fornier B, Pinson B (2012) 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl 5'-monophosphate (AICAR), a highly conserved purine intermediate with multiple effects. Metabolites 2(2):292–302. https://doi.org/10.3390/metabo2020292

  12. Ducker GS, Rabinowitz JD (2015) ZMP: a master regulator of one-carbon metabolism. Mol Cell 57(2):203–204. https://doi.org/10.1016/j.molcel.2015.01.012

  13. Edwards AM (2014) Structure and general properties of flavins. Methods Mol Biol 1146:3–13. https://doi.org/10.1007/978-1-4939-0452-5_1

  14. Gelfand MS, Mironov AA, Jomantas J, Kozlov YI, Perumov DA (1999) A conserved RNA structure element involved in the regulation of bacterial riboflavin synthesis genes. Trends Genet 15(11):439–442

  15. Gronskiy SV, Zakataeva NP, Vitushkina MV, Ptitsyn LR, Altman IB, Novikova AE, Livshits VA (2005) The yicM (nepI) gene of Escherichia coli encodes a major facilitator superfamily protein involved in efflux of purine ribonucleosides. FEMS Microbiol Lett 250(1):39–47. https://doi.org/10.1016/j.femsle.2005.06.051

  16. Guérout-Fleury AM, Shazand K, Frandsen N, Stragier P (1995) Antibiotic-resistance cassettes for Bacillus subtilis. Gene 167(1–2):335–336. https://doi.org/10.1016/0378-1119(95)00652-4

  17. Guo J, Lu Y, Dong H (2006) HPLC-MS analysis of the riboflavin crude product of semisynthesis. J Chromatogr Sci 44(9):552–556

  18. Hümbelin M, Griesser V, Keller T, Schurter W, Haiker M, Hohmann HP, Ritz H, Richter G, Bacher A, van Loon APGM (1999) GTP cyclohydrolase II and 3,4-dihydroxy-2-butanone 4-phosphate synthase are rate-limiting enzymes in riboflavin synthesis of an industrial Bacillus subtilis strain used for riboflavin production. J Ind Microbiol Biotechnol 22:1–7

  19. Hunsucker SA, Mitchell BS, Spychala J (2005) The 5′-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol Ther 107(1):1–30. https://doi.org/10.1016/j.pharmthera.2005.01.003

  20. Hürlimann HC, Laloo B, Simon-Kayser B, Saint-Marc C, Coulpier F, Lemoine S, Daignan-Fornier B, Pinson B (2011) Physiological and toxic effects of purine intermediate 5-amino-4-imidazolecarboxamide ribonucleotide (AICAR) in yeast. J Biol Chem 286(35):30994–31002. https://doi.org/10.1074/jbc.M111.262659

  21. Ishiwa H, Shibahara-Sone H (1986) New shuttle vectors for Escherichia coli and Bacillus subtilis. IV. The nucleotide sequence of pHY300PLK and some properties in relation to transformation. Jpn J Genet 61:515–528

  22. Koo BM, Kritikos G, Farelli JD, Todor H, Tong K, Kimsey H, Wapinski I, Galardini M, Cabal A, Peters JM, Hachmann AB, Rudner DZ, Allen KN, Typas A, Gross CA (2017) Construction and analysis of two genome-scale deletion libraries for Bacillus subtilis. Cell Syst 4(3):291–305. https://doi.org/10.1016/j.cels.2016.12.013

  23. Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessières P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Cordani JJ, Connerton IF, Cummings NJ, Daniel RA, Denziot F, Devine KM, Düsterhöft A, Ehrlich SD, Emmerson PT, Entian KD, Errington J, Fabret C, Ferrari E, Foulger D, Fritz C, Fujita M, Fujita Y, Fuma S, Galizzi A, Galleron N, Ghim SY, Glaser P, Goffeau A, Golightly EJ, Grandi G, Guiseppi G, Guy BJ, Haga K, Haiech J, Harwood CR, Hènaut A, Hilbert H, Holsappel S, Hosono S, Hullo MF, Itaya M, Jones L, Joris B, Karamata D, Kasahara Y, Klaerr-Blanchard M, Klein C, Kobayashi Y, Koetter P, Koningstein G, Krogh S, Kumano M, Kurita K, Lapidus A, Lardinois S, Lauber J, Lazarevic V, Lee SM, Levine A, Liu H, Masuda S, Mauël C, Médigue C, Medina N, Mellado RP, Mizuno M, Moestl D, Nakai S, Noback M, Noone D, O'Reilly M, Ogawa K, Ogiwara A, Oudega B, Park SH, Parro V, Pohl TM, Portelle D, Porwollik S, Prescott AM, Presecan E, Pujic P, Purnelle B, Rapoport G, Rey M, Reynolds S, Rieger M, Rivolta C, Rocha E, Roche B, Rose M, Sadaie Y, Sato T, Scanlan E, Schleich S, Schroeter R, Scoffone F, Sekiguchi J, Sekowska A, Seror SJ, Serror P, Shin BS, Soldo B, Sorokin A, Tacconi E, Takagi T, Takahashi H, Takemaru K, Takeuchi M, Tamakoshi A, Tanaka T, Terpstra P, Togoni A, Tosato V, Uchiyama S, Vandebol M, Vannier F, Vassarotti A, Viari A, Wambutt R, Wedler H, Weitzenegger T, Winters P, Wipat A, Yamamoto H, Yamane K, Yasumoto K, Yata K, Yoshida K, Yoshikawa HF, Zumstein E, Yoshikawa H, Danchin A (1997) The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature 390(6657):249–256. https://doi.org/10.1038/36786

  24. Kuznetsova E, Proudfoot M, Gonzalez CF, Brown G, Omelchenko MV, Borozan I, Carmel L, Wolf YI, Mori H, Savchenko AV, Arrowsmith CH, Koonin EV, Edwards AM, Yakunin AF (2006) Genome-wide analysis of substrate specificities of the Escherichia coli haloacid dehalogenase-like phosphatase family. J Biol Chem 281(47):36149–36161. https://doi.org/10.1074/jbc.M605449200

  25. Larion M, Miller BG (2012) Homotropic allosteric regulation in monomeric mammalian glucokinase. Arch Biochem Biophys 519(2):103–111. https://doi.org/10.1016/j.abb.2011.11.007

  26. Liu L, Liu Y, Shin HD, Chen RR, Wang NS, Li J, Du G, Chen J (2013) Developing Bacillus spp. as a cell factory for production of microbial enzymes and industrially important biochemicals in the context of systems and synthetic biology. Appl Microbiol Biotechnol 97(14):6113–6127. https://doi.org/10.1007/s00253-013-4960-4

  27. Lobanov KV, Errais Lopes L, Korol’kova NV, Tyaglov BV, Glazunov AV, Shakulov RS, Mironov AS (2011) Reconstruction of purine metabolism in Bacillus subtilis to obtain the strain producer of AICAR: a new drug with a wide range of therapeutic applications. Acta Nat 3(2):79–89

  28. Mack M, van Loon AP, Hohmann HP (1998) Regulation of riboflavin biosynthesis in Bacillus subtilis is affected by the activity of the flavokinase/flavin adenine dinucleotide synthetase encoded by ribC. J Bacteriol 180(4):950–955

  29. Malykh EA, Butov IA, Ravcheeva AB, Krylov AA, Mashko SV, Stoynova NV (2018) Specific features of L-histidine production by Escherichia coli concerned with feedback control of AICAR formation and inorganic phosphate/metal transport. Microb Cell Factories 17(1):42–15. https://doi.org/10.1186/s12934-018-0890-2

  30. Matsuhisa A, Suzuki N, Noda T, Shiba K (1995) Inositol monophosphatase activity from the Escherichia coli suhB gene product. J Bacteriol 177(1):200–205. https://doi.org/10.1128/jb.177.1.200-205.1995

  31. Miller JH (1972) Experiments in molecular genetics. Cold Spring Harbor, New York

  32. Mironov AS, Korolkova NV, Errais LL, Semenova LE, Perumov DA, Kreneva RA, Glazunov AV, Akishina RI, Iomantas YAV, Abalakina EG, Stoynova NV, Kozlov YI, Debabov VG (2002) Method for preparing riboflavin, strains bacillus subtilis as producers of riboflavin (variants) application RU2002130592/13A

  33. Morabbi Heravi K, Manzoor I, Watzlawick H, de Jong A, Kuipers OP, Altenbuchner J (2019) Phosphosugar stress in Bacillus subtilis: intracellular accumulation of mannose 6-phosphate derepressed the glcR-phoC operon from repression by GlcR. J Bacteriol 201:e00732–e00718. https://doi.org/10.1128/JB.00732-18

  34. Nicolas P, Mäder U, Dervyn E, Rochat T, Leduc A, Pigeonneau N, Bidnenko E, Marchadier E, Hoebeke M, Aymerich S, Becher D, Bisicchia P, Botella E, Delumeau O, Doherty G, Denham EL, Fogg MJ, Fromion V, Goelzer A, Hansen A, Härtig E, Harwood CR, Homuth G, Jarmer H, Jules M, Klipp E, Le Chat L, Lecointe F, Lewis P, Liebermeister W, March A, Mars RA, Nannapaneni P, Noone D, Pohl S, Rinn B, Rügheimer F, Sappa PK, Samson F, Schaffer M, Schwikowski B, Steil L, Stülke J, Wiegert T, Devine KM, Wilkinson AJ, van Dijl JM, Hecker M, Völker U, Bessières P, Noirot P (2012) Condition-dependent transcriptome reveals high-level regulatory architecture in Bacillus subtilis. Science 335(6072):1103–1106. https://doi.org/10.1126/science

  35. Perkins JB, Sloma A, Hermann T, Theriault K, Zachgo E, Erdenberger T, Hannett N, Chatterjee NP, Williams V II, Rufo GA Jr, Hatch R, Pero J (1999) Genetic engineering of Bacillus subtilis for the commercial production of riboflavin. J Ind Microbiol Biotechnol 22(1):8–18. https://doi.org/10.1038/sj.jim.2900587

  36. Petersen C (1999) Inhibition of cellular growth by increased guanine nucleotide pools. Characterization of an Escherichia coli mutant with a guanosine kinase that is insensitive to feedback inhibition by GTP. J Biol Chem 274(9):5348–5356. https://doi.org/10.1074/jbc.274.9.5348

  37. Podzelinska K, He SM, Wathier M, Yakunin A, Proudfoot M, Hove-Jensen B, Zechel DL, Jia Z (2009) Structure of PhnP, a phosphodiesterase of the carbon-phosphorus lyase pathway for phosphonate degradation. J Biol Chem 284(25):17216–17226. https://doi.org/10.1074/jbc.M808392200

  38. Porter CM, Miller BG (2012) Cooperativity in monomeric enzymes with single ligand-binding sites. Bioorg Chem 43:44–50. https://doi.org/10.1016/j.bioorg.2011.11.001

  39. Sambrook J, Russell DW (2001) Molecular cloning: laboratory manual, 3rd edn. Cold Spring Harbor, New York

  40. Sarge S, Haase I, Illarionov B, Laudert D, Hohmann HP, Bacher A, Fischer M (2015) Catalysis of an essential step in vitamin B2 biosynthesis by a consortium of broad spectrum hydrolases. Chembiochem 16(17):2466–2469. https://doi.org/10.1002/cbic.201500352

  41. Schallmey M, Singh A, Ward OP (2004) Developments in the use of Bacillus species for industrial production. Can J Microbiol 50:1–17. https://doi.org/10.1139/w03-076

  42. Shatalin KY, Neyfakh AA (2005) Efficient gene inactivation in Bacillus anthracis. FEMS Microbiol Lett 245(2):315–319

  43. Sheremet AS, Gronskiy SV, Akhmadyshin RA, Novikova AE, Livshits VA, Shakulov RS, Zakataeva NP (2011) Enhancement of extracellular purine nucleoside accumulation by Bacillus strains through genetic modifications of genes involved in nucleoside export. J Ind Microbiol Biotechnol 38(1):65–70. https://doi.org/10.1007/s10295-010-0829-z

  44. Smirnov SV, Kotliarova VA (2015) Method for producing isoprene using bacterium. Patent WO 2015056813. 2015;A1

  45. Stepanov AI, Zhdanov VG, Kukanova AI, Khaikinson MY, Rabinovich PM, Iomantas JV, Galuchkina ZM (1984) Method for preparing riboflavin. French patent application №3599355

  46. Storer AC, Cornish-Bowden A (1976) Kinetics of rat liver glucokinase: co-operative interactions with glucose at physiologically significant concentrations. Biochem J 159(1):7–14

  47. Terakawa A, Natsume A, Okada A, Nishihata S, Kuse J, Tanaka K, Takenaka S, Ishikawa S, Yoshida KI (2016) Bacillus subtilis 5′-nucleotidases with various functions and substrate specificities. BMC Microbiol 16(1):249–213. https://doi.org/10.1186/s12866-016-0866-5

  48. Willemoës M, Hove-Jensen B, Larsen S (2002) Steady state kinetic model for the binding of substrates and allosteric effectors to Escherichia coli phosphoribosyl-diphosphate synthase. J Biol Chem 275(45):35408–35412. https://doi.org/10.1074/jbc.M006346200

  49. Winkler WC, Cohen-Chalamish S, Breaker RR (2002) An mRNA structure that controls gene expression by binding FMN. Proc Natl Acad Sci U S A 99(25):15908–15913

  50. Yusupova YR, Skripnikova VS, Zakataeva NP (2014) Gene cloning and characterization of a new 5′-nucleotidase from Bacillus subtilis. Proceedings of the 16th International Biotechnology Symposium and Exhibition, Fortaleza, Brazil, Sept, 14-19th, 2014, A257:586–587. http://itarget.com.br/newclients//ibs2014.org/downloads/IBS_2014_final_e-Book.pdf

  51. Zakataeva NP, Nikitina OV, Gronskiy SV, Romanenkov DV, Livshits VA (2010) A simple method to introduce marker-free genetic modifications into the chromosome of naturally nontransformable Bacillus amyloliquefaciens strains. Appl Microbiol Biotechnol 85(4):1201–1209. https://doi.org/10.1007/s00253-009-2276-1

  52. Zakataeva NP, Romanenkov DV, Yusupova YR, Skripnikova VS, Asahara T, Gronskiy SV (2016) Identification, heterologous expression, and functional characterization of Bacillus subtilis YutF, a HAD superfamily 5′-nucleotidase with broad substrate specificity. PLoS One 11(12):e0167580. https://doi.org/10.1371/journal.pone.0167580

  53. Zhang C, Du S, Liu Y, Xie X, Xu Q, Chen N (2015) Strategy for enhancing adenosine production under the guidance of transcriptional and metabolite pool analysis. Biotechnol Lett 37(7):1361–1369. https://doi.org/10.1007/s10529-015-1801-9

  54. Zimmermann H (1992) 5′-Nucleotidase: molecular structure and functional aspects. Biochem J 285(2):345–365. https://doi.org/10.1042/bj2850345

Download references

Acknowledgments

We thank O. Soshnikova for participating in “shotgun” cloning experiments.

Author information

Correspondence to Natalia P. Zakataeva.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical statement

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(PDF 1.36 mb)

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yusupova, Y.R., Skripnikova, V.S., Kivero, A.D. et al. Expression and purification of the 5′-nucleotidase YitU from Bacillus species: its enzymatic properties and possible applications in biotechnology. Appl Microbiol Biotechnol (2020). https://doi.org/10.1007/s00253-020-10428-y

Download citation

Keywords

  • 5′-Nucleotidases (EC 3.1.3.5)
  • Riboflavin producers
  • 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) producers
  • Bacillus subtilis
  • Bacillus amyloliquefaciens